{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:00:17Z","timestamp":1787583617603,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007048","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.clml.2024.07.019","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T09:47:21Z","timestamp":1722592041000},"page":"116-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Incidence of Central Nervous System Relapse in Primary Mediastinal Large B-Cell Lymphoma: Implications for Central Nervous System Prophylaxis"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3503-0773","authenticated-orcid":false,"given":"Izel","family":"Okcu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3174-8877","authenticated-orcid":false,"given":"Allison M.","family":"Bock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2684-192X","authenticated-orcid":false,"given":"Jihao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8582-1219","authenticated-orcid":false,"given":"Muhamad Alhaj","family":"Moustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9184-094X","authenticated-orcid":false,"given":"Han W.","family":"Tun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison C.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick B.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3584-9453","authenticated-orcid":false,"given":"Firas","family":"Baidoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5645-0949","authenticated-orcid":false,"given":"Arushi","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian F.","family":"Kabat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Habermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz S.","family":"Nowakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.clml.2024.07.019_bib0001","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1182\/blood.2020008376","article-title":"Primary mediastinal large B-cell lymphoma","volume":"140","author":"Savage","year":"2022","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.clml.2024.07.019_bib0002","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2559.1986.tb02491.x","article-title":"Large cell lymphoma of the mediastinum: a B-cell tumour of probable thymic origin","volume":"10","author":"ADDIS","year":"1986","journal-title":"Histopathology"},{"issue":"11","key":"10.1016\/j.clml.2024.07.019_bib0003","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/S0046-8177(88)80282-X","article-title":"Thymic medullary cells expressing B lymphocyte antigens","volume":"19","author":"Hofmann","year":"1988","journal-title":"Hum Pathol"},{"issue":"8574","key":"10.1016\/j.clml.2024.07.019_bib0004","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/S0140-6736(87)92622-5","article-title":"The human thymus contains a novel population of B lymphocytes","volume":"2","author":"Isaacson","year":"1987","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.clml.2024.07.019_bib0005","doi-asserted-by":"crossref","first-page":"e464","DOI":"10.1016\/j.clml.2020.12.015","article-title":"Primary mediastinal (thymic) large B-Cell lymphoma: fidelity of diagnosis using WHO criteria","volume":"21","author":"Fairchild","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"20","key":"10.1016\/j.clml.2024.07.019_bib0006","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.clml.2024.07.019_bib0007","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.clml.2024.07.019_bib0008","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","article-title":"Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma","volume":"198","author":"Rosenwald","year":"2003","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.clml.2024.07.019_bib0009","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1200\/JCO.1999.17.8.2479","article-title":"CNS involvement in primary mediastinal large B-cell lymphoma","volume":"17","author":"Bishop","year":"1999","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.clml.2024.07.019_bib0010","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1002\/1097-0142(19821201)50:11<2486::AID-CNCR2820501138>3.0.CO;2-G","article-title":"Primary Non-Hodgkin's lymphoma of the mediastinum","volume":"50","author":"Levitt","year":"1982","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.clml.2024.07.019_bib0011","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11899-014-0219-0","article-title":"Primary mediastinal large B-cell lymphoma","volume":"9","author":"Dabrowska-Iwanicka","year":"2014","journal-title":"Curr Hematol Malig Rep"},{"issue":"12","key":"10.1016\/j.clml.2024.07.019_bib0012","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1200\/JCO.1993.11.12.2306","article-title":"Primary mediastinal B-cell lymphoma with sclerosis: an aggressive tumor with distinctive clinical and pathologic features","volume":"11","author":"Lazzarino","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2024.07.019_bib0013","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.critrevonc.2017.01.009","article-title":"Primary mediastinal large B-cell lymphoma","volume":"113","author":"Martelli","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"issue":"18","key":"10.1016\/j.clml.2024.07.019_bib0014","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1002\/cncr.25278","article-title":"Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma","volume":"116","author":"Abramson","year":"2010","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.clml.2024.07.019_bib0015","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1182\/blood-2008-04-151563","article-title":"CNS Hodgkin lymphoma","volume":"112","author":"Gerstner","year":"2008","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.clml.2024.07.019_bib0016","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1002\/1097-0142(19831001)52:7<1301::AID-CNCR2820520728>3.0.CO;2-5","article-title":"Intracranial Hodgkin's disease. A report of 12 cases and review of the literature","volume":"52","author":"Sapozink","year":"1983","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.clml.2024.07.019_bib0017","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1080\/10428190410001673409","article-title":"Intracranial presentation of systemic Hodgkin's disease","volume":"45","author":"Hirmiz","year":"2004","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"10.1016\/j.clml.2024.07.019_bib0018","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.blre.2006.02.001","article-title":"CNS prophylaxis in lymphoma: who to target and what therapy to use","volume":"20","author":"Hill","year":"2006","journal-title":"Blood Rev"},{"issue":"24","key":"10.1016\/j.clml.2024.07.019_bib0019","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1182\/blood.2019004296","article-title":"Outcome of primary mediastinal large B-cell lymphoma using R-CHOP: impact of a PET-adapted approach","volume":"136","author":"Hayden","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.clml.2024.07.019_bib0020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/hon.2012","article-title":"Isolated central nervous system relapses in primary mediastinal large B-cell lymphoma after CHOP-like chemotherapy with or without Rituximab","volume":"31","author":"Papageorgiou","year":"2013","journal-title":"Hematol Oncol"},{"issue":"21","key":"10.1016\/j.clml.2024.07.019_bib0021","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1182\/blood.V120.21.303.303","article-title":"The outcome of primary mediastinal large B-Cell lymphoma (PMBCL) in the R-CHOP treatment era","volume":"120","author":"Savage","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.clml.2024.07.019_bib0022","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3109\/10428194.2013.810738","article-title":"Treatment of primary mediastinal B-cell lymphoma with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone is associated with a high rate of primary refractory disease","volume":"55","author":"Soumerai","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"10.1016\/j.clml.2024.07.019_bib0023","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00000421-198910000-00013","article-title":"Mediastinal diffuse large-cell lymphoma with sclerosis: a condition with a poor prognosis","volume":"12","author":"Haioun","year":"1989","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clml.2024.07.019_bib0024","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/hon.3096","article-title":"Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B-cell lymphoma in the rituximab era","volume":"41","author":"Vassilakopoulos","year":"2023","journal-title":"Hematol Oncol"},{"issue":"19","key":"10.1016\/j.clml.2024.07.019_bib0025","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1182\/bloodadvances.2021004778","article-title":"Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study","volume":"5","author":"Camus","year":"2021","journal-title":"Blood Adv"},{"issue":"26","key":"10.1016\/j.clml.2024.07.019_bib0026","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1200\/JCO.2015.65.6520","article-title":"CNS International prognostic index: a risk model for CNS relapse in patients with diffuse large B-Cell lymphoma treated with R-CHOP","volume":"34","author":"Schmitz","year":"2016","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clml.2024.07.019_bib0027","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/annonc\/mdl327","article-title":"Incidence and risk factors of central nervous system recurrence in aggressive lymphoma: a survey of 1693 patients treated in protocols of the German high-grade Non-Hodgkin's lymphoma study group (DSHNHL)","volume":"18","author":"Boehme","year":"2007","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.clml.2024.07.019_bib0028","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1200\/JCO.2008.16.8021","article-title":"Natural history of CNS relapse in patients with aggressive non-Hodgkin's lymphoma: a 20-year follow-up analysis of SWOG 8516: the southwest oncology group","volume":"27","author":"Bernstein","year":"2009","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.clml.2024.07.019_bib0029","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1182\/blood.2021012888","article-title":"Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions","volume":"139","author":"Orellana-Noia","year":"2022","journal-title":"Blood"},{"issue":"35","key":"10.1016\/j.clml.2024.07.019_bib0030","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1200\/JCO.23.00365","article-title":"High-dose methotrexate as CNS prophylaxis in high-risk aggressive B-Cell lymphoma","volume":"41","author":"Lewis","year":"2023","journal-title":"J Clin Oncol"},{"issue":"27","key":"10.1016\/j.clml.2024.07.019_bib0031","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265024002908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265024002908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T10:59:20Z","timestamp":1738061960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265024002908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2152265024002908"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2024.07.019","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of Central Nervous System Relapse in Primary Mediastinal Large B-Cell Lymphoma: Implications for Central Nervous System Prophylaxis","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2024.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}